(Q37699345)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187707%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187707%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187707%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Filippo Belardelli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187707%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Franca Moretti

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187707%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187707%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187707%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187707%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187707%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

204-209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187707%20AND%20SRC:MED&resulttype=core&format=json

Fifty years of interferon research: aiming at a moving target

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

The type I interferon receptor: structure, function, and evolution of a family business.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Cytokine therapeutics: lessons from interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

The antitumor effects of interferon: a personal history

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Cytokines as a link between innate and adaptive antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Syndromes and complications of interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Type I interferon in systemic lupus erythematosus and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Interferon-alpha in tumor immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Induction of TH1 and TH2 responses: a key role for the 'natural' immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Type I interferon-mediated stimulation of T cells by CpG DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Type I interferons keep activated T cells alive

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Origin, maturation and antigen presenting function of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Taking dendritic cells into medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

International meeting on cancer vaccines: how can we enhance efficacy of therapeutic vaccines?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

Evaluation of the effects of human leukocyte IFN-α on the immune response to the HBV vaccine in healthy unvaccinated individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

IFN-α-conditioned dendritic cells are highly efficient in inducing cross-priming CD8+ T cells against exogenous viral antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916930903510880

10.3109/08916930903510880

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20187707%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference